MedTrace Logo

Observational Study of HIV Infected Women Previously Enrolled in Other Microbicide Trials

NCT00514098 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 479

Last updated 2021-06-21

No results posted yet for this study

Summary

A new approach to HIV prevention currently being studied includes the use of topical microbicides and orally administered anti-HIV drugs. The purpose of this study is to better understand the impact of microbicides in women who are diagnosed with HIV-1 during participation in previous microbicide trials.

Conditions

  • HIV Infections

Sponsors & Collaborators

  • National Institute of Allergy and Infectious Diseases (NIAID)

    collaborator NIH

  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

    collaborator NIH

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Microbicide Trials Network

    lead NETWORK

Principal Investigators

  • Sharon A. Riddler, MD · University of Pittsburgh

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-08-25
Primary Completion
2019-06-30
Completion
2019-06-30

Countries

  • Malawi
  • South Africa
  • Uganda
  • Zambia
  • Zimbabwe

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00514098 on ClinicalTrials.gov